Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2003
07/02/2003EP0781129B1 Pharmaceutical preparation containing metformin and a process for producing it
07/02/2003EP0758248B1 Formulations for factor ix
07/02/2003EP0660714B1 Novel liposomal drug delivery systems
07/02/2003EP0626864B1 Topical composition containing hyaluronic acid and nsaids
07/02/2003EP0578780B1 Suppression of thromboxane levels by percutaneous administration of aspirin
07/02/2003CN1427891A Anti-EGFRvIII scFv with improved cytotoxi city and yield, immunotoxins based thereon, and methods of use thereof
07/02/2003CN1427881A Low ionic strength ophthalmic compositions
07/02/2003CN1427857A Polyurethane and use thereof for modifying rheological properties
07/02/2003CN1427730A Medicinal aerosol formulation
07/02/2003CN1427727A Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
07/02/2003CN1427717A Hydrophilic/lipophilic polymeric matrix dosage for mulation
07/02/2003CN1427716A Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof
07/02/2003CN1427715A Urogenital or anorectal transmucosal vaccine delivery system
07/02/2003CN1426816A Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique
07/02/2003CN1112929C Slow-release pharmaceutical formulations containing mizolastin
07/02/2003CN1112927C Pharmaceutical composition of corpus albicans emulsifier type lipophilic compound
07/02/2003CN1112926C Composition comprising 5-[4-(2-(n-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
07/02/2003CN1112924C Rapamycin formulation for TV injection
07/02/2003CN1112921C Compositions containing micronized nebivolol
07/02/2003CN1112919C Controlled release-initiation and controlled release-rate pharamceutical composition
07/02/2003CN1112918C Ophthalmic composition with decreased viscosity
07/01/2003US6586574 Lyophilized composition comprising a protein and glycylglycine as a bulking agent; optionally in combination with a sugar, sugar alcohol, and/or an amino acid
07/01/2003US6586573 Comprising a bulking agent, stabilizing agents, sodium chloride and a buffering agent; decreased risk of transmitting a virus; used in treating hemophilia
07/01/2003US6586524 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
07/01/2003US6586473 Topical drug delivery composition and method
07/01/2003US6586444 Medicinal compositions
07/01/2003US6586440 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme
07/01/2003US6586407 Injectable pharmaceutical formulations for partricin derivatives
07/01/2003US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof
07/01/2003US6586398 Chemically modified novel erythropoietin stimulating protein compositions and methods
07/01/2003US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization
07/01/2003US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
07/01/2003US6586012 To mask the unpleasant taste of pharmaceuticals or nutritional supplements
07/01/2003US6586008 For delivery to the pulmonary system; particles consist of a therapeutic, prophylactic or diagnostic agent, or any combination thereof, an amino acid or salt thereof, and a phospholipid or combination of phospholipids
07/01/2003US6586003 Emulsion and micellar formulations for the delivery of biologically active substances to cells
07/01/2003US6586002 Enhanced circulation effector composition and method
07/01/2003US6586001 Neutral lipopolymer and liposomal compositions containing same
07/01/2003US6586000 Hydroxide-releasing agents as skin permeation enhancers
07/01/2003US6585998 Nutraceutical composition
07/01/2003US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
07/01/2003US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level
07/01/2003US6585993 Controlled release neurotoxin system
07/01/2003US6585974 Preventives for hepatopathy
07/01/2003US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone
07/01/2003US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
07/01/2003US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
07/01/2003US6585963 Nail compositions and methods of administering same
07/01/2003US6585959 Excipient having different particle size distribution are added in alternate layers into a suitable mixing vessel; mixing together using a suitable mixer, wherein a portion of the excipient having the larger particle size is added first
07/01/2003US6585958 Medicinal aerosol formulations
07/01/2003US6585957 Medicinal aerosol formulation
07/01/2003US6585956 Dendritic-platinate drug delivery system
07/01/2003CA2161225C Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
07/01/2003CA2080868C Novel hetero-branched cyclodextrins and method of preparing them
06/2003
06/26/2003WO2003052117A2 Methods and products related to non-viral transfection
06/26/2003WO2003052095A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003WO2003052091A1 Growth factor modified protein matrices for tissue engineering
06/26/2003WO2003052060A2 Beta-cyclodextrin dimers and phthalocyanines and uses thereof
06/26/2003WO2003051979A2 Compositions and methods for high sorption of skin materials and delivery of sulfur
06/26/2003WO2003051907A2 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
06/26/2003WO2003051400A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003WO2003051399A2 Use of substances with an increased molecular weight in tumour therapy
06/26/2003WO2003051398A1 Parenteral composition of paracetamol
06/26/2003WO2003051390A1 Use of a polypeptide for treatment of pruritus in animals
06/26/2003WO2003051385A1 Pharmaceutical formulation comprising cyclosporin and use thereof
06/26/2003WO2003051375A1 Stabilized brivudine topical formulations
06/26/2003WO2003051373A1 Liquid bisphosphonate formulations for bone disorders
06/26/2003WO2003051352A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
06/26/2003WO2003051340A1 New film coating
06/26/2003WO2003051338A1 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
06/26/2003WO2003051337A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
06/26/2003WO2003051336A1 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen
06/26/2003WO2003051334A2 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051332A1 Ophthalmic compositions comprising two different polyanionic components for lubricating eyes and methods for making and using same
06/26/2003WO2003051330A1 Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof
06/26/2003WO2003051304A2 Bioadhesive drug delivery system with enhanced gastric retention
06/26/2003WO2003051300A2 Metal complexes and formulations of rifamycin analogues and uses therof
06/26/2003WO2003051299A2 Sulfhydryl rifamycins and uses thereof
06/26/2003WO2003051297A2 Aqueous ifosfamide composition
06/26/2003WO2003051294A2 Mitocidal compositions and methods
06/26/2003WO2003051287A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003WO2003051286A2 Hydrogel compositions, devices, and microscale components
06/26/2003WO2003051278A2 Nanoparticle delivery vehicle
06/26/2003WO2003051113A1 Methods and compositions for controlled release of drugs
06/26/2003WO2003030920A9 An antispasmodic agent spaced drug delivery system
06/26/2003WO2003028648A3 Veterinaire florfenicol formulation that is syringeable under cold weather conditions
06/26/2003WO2003026612A3 Dosage forms having an inner core and outer shell
06/26/2003WO2003026610A3 Process for the preparation of fast dissolving dosage form
06/26/2003WO2003025125A3 Selective substrates for matrix metalloproteinases
06/26/2003WO2002065834A8 Novel formulations of carvedilol
06/26/2003WO2002058733A3 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
06/26/2003WO2001097778A8 Amphotericin b structured emulsion
06/26/2003US20030120056 TIE ligand homologues
06/26/2003US20030120045 Immobilization onto polyoxyethylene glycol
06/26/2003US20030120033 Polypeptides; immunoassay using antibodies
06/26/2003US20030119911 Levothyroxine sodium and liothyronine sodium in solid form with microcrystalline cellulose; treating hypothyroidism and thyroid hormone replacement therapy
06/26/2003US20030119898 6-96 mu g of a 7-hydroxy-cyclopenta-3-one(b)pyran derivatives
06/26/2003US20030119893 Non-selective beta-blocker with a vasodilating component
06/26/2003US20030119872 Process for preparing non-hygroscopic sodium valproate composition
1 ... 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 ... 1712